TY - JOUR
T1 - Playing with fire
AU - Armitage Harper, C.
AU - Beck, Kinley D.
AU - Chang, Emmanuel
AU - Young, Ryan
AU - Moshfeghi, Darius M.
N1 - Funding Information:
© 2020 Harper, Beck, Chang, Young, Moshfeghi; licensee SLACK Incorporated. This is an Open Access article distributed under the terms of the Cre - ative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0). This license allows users to copy and distribute, to remix, transform, and build upon the article, for any purpose, even commercially, provided the author is at-tributed and is not represented as endorsing the use made of the work. Originally submitted July 30, 2020. Revision received July 30, 2020. Accepted for publication August 20, 2020. Dr. Moshfeghi received personal fees from Regeneron, Bayer, and Novartis, as well as grants from Genentech, outside the submitted work. The remaining authors report no relevant financial disclosures. Dr. Moshfeghi did not participate in the editorial review of this manuscript. Address correspondence to C. Armitage Harper III, MD, Retina Associates of Austin, Austin, TX; email: [email protected]. doi: 10.3928/23258160-20201005-01
Publisher Copyright:
© 2020 Harper, Beck, Chang, Young, Moshfeghi; licensee SLACK Incorporated. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0). This license allows users to copy and distribute, to remix, transform, and build upon the article, for any purpose, even commercially, provided the author is at-tributed and is not represented as endorsing the use made of the work.
PY - 2020/10
Y1 - 2020/10
N2 - The authors present their concerns surrounding data presented in studies from 2018 and 2020 regarding very low dose bevacizumab for the treatment of retinopathy of prematurity.
AB - The authors present their concerns surrounding data presented in studies from 2018 and 2020 regarding very low dose bevacizumab for the treatment of retinopathy of prematurity.
UR - http://www.scopus.com/inward/record.url?scp=85094931063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094931063&partnerID=8YFLogxK
U2 - 10.3928/23258160-20201005-01
DO - 10.3928/23258160-20201005-01
M3 - Review article
C2 - 33104220
AN - SCOPUS:85094931063
SN - 2325-8160
VL - 51
SP - 542
EP - 544
JO - Ophthalmic Surgery Lasers and Imaging Retina
JF - Ophthalmic Surgery Lasers and Imaging Retina
IS - 10
ER -